Search all trials

Find therapies in clinical trials near you – page 7

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Rheumatoid arthritis

Not recruiting

Registered drugNo placebo

Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

Registered drugNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Acute coronary syndrome

Not recruiting

Registered drug

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Atrial fibrillation

Not recruiting

Registered drug

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Andexanet Alfa

Contact Research Centre

Arteriosclerosis

Not recruiting

Registered drug

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Inclisiran

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

Registered drugNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Cytomegalovirus immunisation

Not recruiting

Registered drug

Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40

Registered drug

Estonia

Participants:0–17 years · 18–64 years · Healthy volunteers
Substances:Sodium Chloride

Contact Research Centre

Chronic lymphocytic leukaemia+3

Not recruiting

InvestigationalNo placebo

Evaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies

InvestigationalNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:Nemtabrutinib

Contact Research Centre

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Not recruiting

Registered drugNo placebo

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drugNo placebo

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Registered drugNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Multifocal motor neuropathy

Not recruiting

Registered drug

Study comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Empasiprubart

Contact Research Centre

Influenza immunisation

Not recruiting

Registered drugNo placebo

Study on the Safety and Immune Response of a High-Dose Influenza Vaccine in Adults Aged 60 and Over, Comparing Trivalent Influenza Vaccine with a Drug Combination

Registered drugNo placebo

Estonia

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)

Contact Research Centre

Varicella

Not recruiting

Registered drugNo placebo

Study on the Safety of a New Chickenpox Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

Registered drugNo placebo

Estonia

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896

Contact Research Centre

Find therapies in clinical trials near you – page 7

147 trials match your criteria

Rheumatoid arthritis

Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

Acute coronary syndrome

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Atrial fibrillation

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Arteriosclerosis

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Hepatocellular carcinoma

Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

Cytomegalovirus immunisation

Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40

Chronic lymphocytic leukaemia+3

Evaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Colitis ulcerative

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Multifocal motor neuropathy

Study comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy

Influenza immunisation

Study on the Safety and Immune Response of a High-Dose Influenza Vaccine in Adults Aged 60 and Over, Comparing Trivalent Influenza Vaccine with a Drug Combination

Varicella

Study on the Safety of a New Chickenpox Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.